Financhill
Back

Alterity Therapeutics Quote, Financials, Valuation and Earnings

Alterity Therapeutics Price Quote

$1.09
+0.04 (+3.81%)
(Updated: November 21, 2024 at 9:50 AM ET)

Alterity Therapeutics Key Stats

Sell
22
Alterity Therapeutics (ATHE) is a Sell

Day range:
$1.05 - $1.11
52-week range:
$1.01 - $5.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
16.6K
Avg. volume:
11.9K
1-year change:
-55.88%
Market cap:
$9.6M
Revenue:
$0
EPS:
$-0.71

How Much Does Alterity Therapeutics Make?

Is Alterity Therapeutics Growing As A Company?

  • What Is Alterity Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.39%
  • What Is Alterity Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Alterity Therapeutics Stock Price Performance

What Is Alterity Therapeutics 52-Week High & Low?

Alterity Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Alterity Therapeutics?

Is Alterity Therapeutics Cash Flow Positive?

  • What Is ATHE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$10.1M
  • What Is Alterity Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $33.8M
  • What Is Alterity Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.4K

Alterity Therapeutics Return On Invested Capital

Data Unavailable

Alterity Therapeutics Earnings Date & Stock Price

Alterity Therapeutics Competitors

Alterity Therapeutics Dividend Yield

Alterity Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -38.88% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.00
Upside from Last Price: 280.95%

Major Shareholders

  • How many ATHE shares are owned by institutional investors?
    151.4K ATHE shares are owned by institutional investors
  • How many ATHE shares are owned by insiders?
    0 ATHE shares are owned by insiders